When EGFR shRNA sequences were applied to pT7/shRNA DNA fragments, a single systemic injection could suppress the expression of EGFR gene in the tumor sites for more than two weeks, substantially inhibiting the ovarian tumor growth. The gene discussed is EGFR; the disease is neoplasm.